Is vyepti a biologic?

Vyepti is classified as a biologic drug [1].

What kind of biologic is Vyepti?

Vyepti is a monoclonal antibody designed to treat or prevent migraine headaches [1]. It targets the calcitonin gene-related peptide (CGRP) pathway [1].

How does Vyepti work for migraine prevention?

Vyepti works by binding to the CGRP molecule [1]. CGRP is believed to play a role in the migraine process, and blocking its action can help prevent migraines [1].

When can I expect Vyepti to be available or how long has it been on the market?

Vyepti was approved by the U.S. Food and Drug Administration (FDA) in February 2020 [1].

Who manufactures Vyepti?

Lundbeck manufactures Vyepti [1].

What is the difference between Vyepti and other migraine treatments?

Vyepti is an injectable biologic, distinguishing it from oral medications for migraine prevention. Unlike some older oral preventive treatments, Vyepti targets the CGRP pathway, which is a more recent approach to migraine therapy [1].